Body Dysmorphic Disorder, also known as dysmorphophobia, is related to personality disorder and eating disorder. An important gene associated with Body Dysmorphic Disorder is DLGAP3 (DLG Associated Protein 3), and among its related pathways/superpathways are Transmission across Chemical Synapses and Protein-protein interactions at synapses. The drugs Fluoxetine and Levetiracetam have been mentioned in the context of this disorder. Affiliated tissues include brain and breast, and related phenotype is behavior/neurological.